共 50 条
- [42] Real-World Outcomes of Anti-VEGF Treatment for Neovascular Age-Related Macular Degeneration in Turkey: A Multicenter Retrospective Study, Bosphorus Retina Study Group Report No: 1 [J]. TURK OFTALMOLOJI DERGISI-TURKISH JOURNAL OF OPHTHALMOLOGY, 2018, 48 (05): : 232 - 237
- [43] Survey of Real-World Research Workforce, Training, and Education: Report from the DIA Real-World Outcomes Task Force [J]. DRUG INFORMATION JOURNAL, 2012, 46 (02): : 185 - 191
- [44] Survey of Real-World Research Workforce, Training, and Education: Report from the DIA Real-World Outcomes Task Force [J]. Drug information journal : DIJ / Drug Information Association, 2012, 46 : 185 - 191
- [46] Retrospective analysis of OCT parameters after intravitreal anti-VEGF inhibitors in neovascular AMD patients in a real-world setting [J]. International Ophthalmology, 2023, 43 : 13 - 25
- [49] Ranibizumab for the treatment of wet AMD: a summary of real-world studies [J]. EYE, 2016, 30 (02) : 270 - 286
- [50] Intravitreal faricimab for neovascular age-related macular degeneration previously treated with traditional anti-VEGF compounds: a real-world prospective study [J]. Graefe's Archive for Clinical and Experimental Ophthalmology, 2024, 262 : 1151 - 1159